Clinical Trials Logo

Hip Fractures clinical trials

View clinical trials related to Hip Fractures.

Filter by:

NCT ID: NCT05224167 Not yet recruiting - Clinical trials for Preoperative Anxiety

Melatonin Versus Hydroxizin for Pre Operative Anxiety in Elderly Patients With Hip Fracture

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

prospective randomized trial including adukt patients scheduled for hip fracture surgery, Randomization into 2 groups: Group A: Hydroxizin peroperatively Group B: Melatonin pre operatively

NCT ID: NCT05199870 Recruiting - Hip Fractures Clinical Trials

MDR - PMCF Study for Echo FX Stem With RingLoc Bipolar Acetabular Cup and Femoral Head

Start date: December 17, 2021
Phase:
Study type: Observational

The objective of this retrospective enrollment and prospective follow-up study is to confirm safety, performance, and clinical benefits of the Echo FX Stem with the RingLoc Bipolar Acetabular Cup and Femoral Head in hip hemiarthroplasty (implants and instrumentation) at a minimum of 10 years follow-up. All available retrospective data will be collected from each patient and a prospective aspect to the study will be necessary to reach the 10-year time point.

NCT ID: NCT05197335 Active, not recruiting - Hip Fractures Clinical Trials

Observational Clinical Study on Elderly Patients With Fracture of the Proximal Femur Treated With the Chimaera Nail

Chimaera
Start date: July 9, 2020
Phase:
Study type: Observational

This is an observational, prospective and multicenter clinical investigation that is part of the active materiovigilance plan that Orthofix Srl, in agreement with its Notified Body. The sponsor has planned to actively collect clinical data relating to the use of Chimaera Intramedullary Nail in a representative number of users and elderly patients with fractures of the proximal femur. The data obtained from this clinical investigation will be used to complete the pre-market clinical evaluation carried out on the Chimaera with post-market clinical data from the use of the device in normal clinical practice.

NCT ID: NCT05173155 Recruiting - Hip Fractures Clinical Trials

Comparison of Direct Anterior Approach vs. Lateral Hemiarthroplasty for Femoral Neck Fracture Repair

Start date: May 30, 2022
Phase: N/A
Study type: Interventional

Recent research has demonstrated that a hemiarthroplasty (replacement of half the joint) has lower rates of post-surgical complications than a total hip arthroplasty does. However, surgeons tend to vary in their approach to hemiarthroplasties. The lateral approach, which involves making an incision at the side of the patient's hip, requires surgeons to cut through the muscle to access the hip, which has been associated with greater muscle damage and slower rates of recovery. On the other hand, the direct anterior approach does not require the cutting of the patient's muscle and is therefore associated with minimal muscle damage and faster rates of recovery. This study will aim to assess the impact of the surgical approach (Direct Anterior Approach vs. Lateral approach) during hemiarthroplasty on patients' short-term mobility, quality of life, function, pain, and safety parameters.

NCT ID: NCT05150249 Recruiting - Hip Fractures Clinical Trials

Prospective Observational Study Based on a Cohort of Geriatric Patients With Hip Fracture Treated in the Centers Belonging to the GIOG Group

GIOG
Start date: July 15, 2019
Phase:
Study type: Observational [Patient Registry]

The study aims to collect the clinical activity and management data of the Orthogeriatrics and Orthopedics Units participating in the study on a continuous and long-term basis. By collecting clinical data and comparing the performance of the various centers, the study aims to guide the participating centers towards the principles of good clinical practice in orthogeriatrics.

NCT ID: NCT05144191 Active, not recruiting - Clinical trials for Rheumatoid Arthritis

Insignia™ Hip Stem Outcomes Study

Start date: February 7, 2022
Phase: N/A
Study type: Interventional

The objective of this study is to evaluate the safety and effectiveness of the Insignia™ Hip Stem for global market access and post-market clinical follow-up up to 10 years postoperative.

NCT ID: NCT05142462 Active, not recruiting - Hip Fractures Clinical Trials

Post Market Clinical Follow-up of EUROSCUP Fixe Acetabular Cup

Start date: October 27, 2021
Phase:
Study type: Observational

EUROSCUP Fixe is intended for use in primary and revision total hip replacement surgery. Hip replacement is intended to provide increased patient mobility and reduce pain by replacing the damages hip joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components. As part of post market vigilance, EUROS will collect data on EUROSCUP Fixe performances and safety

NCT ID: NCT05141981 Completed - Sarcopenia Clinical Trials

Sarcopenia and Its Associated Factors Among Hip Fractures Patients

Start date: November 20, 2021
Phase:
Study type: Observational

1. Asses the prevalence of sarcopenia in hip fracture patients in Truama hospital at Assuit University 2. To study the associated factors of sarcopenia in hip fracture patients in Trauma hospital at Assuit University

NCT ID: NCT05133648 Active, not recruiting - COVID-19 Clinical Trials

Anesthesia Technique in COVID-19 Positive Hip Fracture Patients

Start date: January 5, 2023
Phase:
Study type: Observational

Patients with COVID undergoing hip fracture repair have high mortality rates. If spinal anesthesia is associated with decreased rates of mortality, this study could provide hypothesis generating data for prospective studies. Investigators hypothesize that spinal anesthesia (SA) is associated with decreased mortality compared to general anesthesia (GA) for patients undergoing hip fracture surgery. The primary objective is to determine for patients undergoing hip surgery with COVID-19 infection, whether SA, as compared to GA, is associated with a lower rate of mortality 30 days postoperatively. The secondary objective is to determine whether SA, as compared to GA, is associated with a lower rate of morbidity 30 days postoperatively. Investigators will be analyzing a data set provided by the National Surgical Quality Improvement Program (NSQIP). Descriptive statistics will be performed. Multivariable logistic regression will be performed for the primary and secondary objectives.

NCT ID: NCT05105906 Recruiting - Delirium Clinical Trials

Post-operative Delirium (POD) in Patients Undergoing Hip Fracture Surgery

Start date: May 1, 2021
Phase:
Study type: Observational

The primary endpoint of the study is the appearance of Post Operative Delirium within the first 3 months. The secondary endpoints are the development of POCD, dementia of any type of new onset at 12 months, mortality at 30 days, postoperative hospitalization time (including rehabilitation performed within the Polyclinic).. The analysis of the risk factors of POD and their correlation with the development of POCD/Dementia in the post-surgery period will provide important information for the optimization of the management path of these patients at an individual level , with inevitable repercussions on the possibility of reintegration into social and family life